We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser’s cookie settings at any time. Please review our privacy policy for more information. OK
The healthcare industry has had no shortage of upheaval and sizeable business challenges. As we prepare to weather a new round of political debate and shifting alliances among the largest players, boards and management teams must press on in their transformation journey and carefully consider all possible avenues for financial stability and a competitive edge.
It’s in this context we offer our annual look at the most current and pressing areas for healthcare organizations where compensation may play a significant role. We believe many boards are or soon will be talking about:
Many different types of companies are now entering the healthcare marketplace and disrupting medicine’s traditional delivery channels by focusing directly on healthcare consumers. We outline some recent examples and their expected impacts, as well as the challenge these changes pose for compensation committees in the healthcare space.
These collaborations between retail, finance, technology, and insurance companies constitute true disruptive innovation and will upend the way individuals and families encounter immediate and primary care, as well as obtain and pay for prescriptions. Patients’ waiting time to access medical care is a prime example. “Access to Care” measurements continue to be critically important to providers for care quality and reimbursement and often appear in a healthcare executive’s incentive compensation program. Traditionally those leaders able to drive down the number of days or weeks between a patient requesting an appointment and seeing a physician were rewarded with some portion of an incentive award. These new disruptive partnerships are already changing the conversation from days to hours and minutes. More traditional providers are likely to be perceived by consumers as “too little, too late.”
Healthcare compensation committees should be aware, however, that accelerating service or utilizing technology alone will not constitute the type of innovation needed to survive and succeed against these newer for-profit retailers, which are experienced in giving the customer what they want while turning a profit. As digital connectedness enables real-time video and audio interactions between medical personnel and patients in disparate locations, traditional benchmarks measuring gradual improvements like “third next available appointment” will fall away. True disruptive innovation only succeeds when it replaces high cost and complexity with simplicity, convenience, accessibility, and affordability—and achieves effective outcomes.
Executive compensation arrangements will need to shift to align with and track an organization’s ability to accelerate simultaneous improvements across clinical outcomes, length of service cycle, patient experience, consumer cost, financial efficiency, and operational simplicity.
Typical healthcare variable compensation plans measure organization performance in areas such as care quality, finance, patient ratings, compliance, employee ratings, etc. and executives may earn some portion of their incentive by performing well against some metrics, even while performing poorly against others. Healthcare organizations seeking to truly disrupt their status quo and innovate in care delivery will develop incentive compensation arrangements that define the end-vision the board seeks. These compensation plans will likely be designed so that incentive awards are generated only when the organization demonstrates success across all performance areas simultaneously and thus is able to achieve its stated mission.
Over the past few years, executive compensation program design in healthcare has focused on how to best ensure a strong focus on “pay for performance.” Boards and senior management teams spend a significant amount of time discussing:
What sometimes gets lost in the conversation is that executive compensation programs should not only pay for performance, but they also need to be competitive in order to attract and—importantly—retain the executive team. Boards seeking to implement a balance between pay for performance and retention in their executive compensation program design might consider some of the following:
In developing or updating executive compensation programs, boards and senior management teams should be mindful that the programs need to meet the organization’s pay-for-performance and executive retention objectives. Well-designed programs which achieve both of these goals will facilitate the organization’s achievement of its mission and business objectives.
Among compensation committees and senior executive teams, it is often said that “incentives drive behavior” or “incentives drive performance.” We believe these statements are fundamentally sound but can be somewhat simplistic as they do not take into consideration the myriad other factors beyond pay which impact individual behaviors and ultimately translate into individual and organization performance. The possibility of other influential motivations is more likely in an industry such as healthcare.
Executives choose to work in healthcare for many reasons, but often there are attractive characteristics of the industry not available elsewhere. One is the social mission—the interest in working for an organization that improves the lives of people in their communities. This may appeal to some of the “intrinsic” (i.e., innate or internal) drivers of executives especially drawn to healthcare who want to have the ability to make decisions in the best interests of the community. Often, because executives’ internal needs can be met in the healthcare industry, some organizations may be able to attract and retain high quality talent but at a somewhat lower “price” than would be required in another industry or type of organization, such as a for-profit entity which often has a more singular, financial endeavor. The growing presence of leaders from large retailers, commercial insurers, and other for-profits seeking to disrupt the healthcare industry and help lead its transformation will presumably have an impact on these dynamics.
This balance between intrinsic and extrinsic motivators (compensation is one of the latter) adds significant complexity to executive pay program design in the healthcare industry relative to others. Healthcare organizations need to develop incentive plans that support the achievement of multiple aspects of the organization’s performance—financial, patient care and quality, reimbursement rates, and the like—while also aligning the mission, business goals, and culture of the organization with the interests of the executive team. In designing these plans, the following guidelines may be helpful:
In 2018, gender-based pay issues became highly visible across industries and geographies. The UK required employers to disclose median and average pay and bonuses for men and women. New state laws went into effect which included broadening the definition from “equal work” to work that is “substantially” similar. Proxy advisory firms and institutional investors are pushing for disclosure of gender pay statistics, with some high-profile organizations voluntarily making such disclosures. And the broader #metoo environment around sexual harassment and discrimination has served to brighten the spotlight on this issue.
Media attention and public disclosures have frequently been focused on the “gender pay gap,” which has generally been reported as 80%—meaning that on average—women are paid 80% of men. New state legislation (as well as current state and federal legislation) focuses on “gender pay equity” and ensuring that men and women who perform substantially similar work are paid the same, unless factors such as performance, experience, and location can reasonably explain pay variations. Given the sensitivity about these issues, clarity is important so as to not create even more confusion and eventually lack of trust.
It will be important for boards to become engaged on gender pay issues for a few reasons:
The issues related to gender equity can be complex and nuanced. It is important that boards make sure management is active in addressing these issues. First, if the state has existing or recently enacted pay equity laws, ensuring that management has plans to assess pay practices and pay levels within the context of pay equity will be important. Second, understanding the pay gap that may exist is important, as well as developing longer-term plans to address the gap. With a baseline understanding of the pay gap, an annual review to monitor progress can help inform potential policy changes. Finally, consideration should be given to how the organization will manage both internal and external communications around this sensitive, yet important topic.
Since the expansion of the regulatory environment via Sarbanes-Oxley and Dodd-Frank implementations, board of director and committee roles have increased dramatically, not only for publicly-traded companies, but for all types of organizations across all industries. The rise of shareholder activism shines light on the fact that investors and stakeholders are increasingly concerned about social issues not traditionally discussed in the board room: diversity; ethics; and corporate, social, and environmental responsibility.
We’re seeing the role of the compensation committee moving beyond the traditional realm of compensation based on budget, target pay, and quantitative lenses to include broader strategy, human resources, and corporate social responsibility aspects that can drive additional value for firms. While this trend is most noticeable within publicly-traded companies, it is also gaining traction among healthcare organizations who view these approaches as “best governance practices.” They are adding board of director compensation, broad-based pay issues, executive succession planning, leadership and talent development, and corporate culture oversight to their agendas.
Outcomes include organizations updating their compensation philosophy to include statements confirming commitment to fair and equitable compensation to all employees within the organization, expanding ethics and morality clauses in employment agreements, and reviewing and modifying clawback provisions.
Several organizations have gone so far as to expand or change the name of their compensation committee to directly reference the HR, talent, and/or leadership matters that are actively covered by the committee. (According to a recent study of publicly-traded organizations, more than 20% of committees that focus on compensation also reference other areas of oversight within the committee name.) We expect this trend of an expanding scope to continue for the foreseeable future and for organizations that have not yet been thinking about some of these items, we anticipate increased discussion and action regarding the committee’s roles and responsibilities.
As we have learned in the past decade or so, there are no simple answers to healthcare reform. While the scope of the challenges facing the healthcare industry and its leaders is vast, there are many advancements taking place and new models are becoming the norm. While they are not a magic wand, carefully constructed compensation plans for the executive leaders enacting this change can provide a useful and effective tool for boards.